BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16021474)

  • 41. Walker 256 tumour growth causes marked changes of glutamine metabolism in rat small intestine.
    Ramos Lima MM; de Mello MA; Curi R
    Cell Biochem Funct; 2002 Jun; 20(2):107-13. PubMed ID: 11979506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A rapid method to study heterogeneous gene expression in liver by direct assay of messenger RNA from periportal and perivenous cell lysates.
    Saarinen J; Saarelainen R; Lindros KO
    Hepatology; 1993 Mar; 17(3):466-9. PubMed ID: 8444421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. C75 activates malonyl-CoA sensitive and insensitive components of the CPT system.
    Nicot C; Napal L; Relat J; González S; Llebaria A; Woldegiorgis G; Marrero PF; Haro D
    Biochem Biophys Res Commun; 2004 Dec; 325(3):660-4. PubMed ID: 15541339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metoprolol represses PGC1alpha-mediated carnitine palmitoyltransferase-1B expression in the diabetic heart.
    Sharma V; Dhillon P; Parsons H; Allard MF; McNeill JH
    Eur J Pharmacol; 2009 Apr; 607(1-3):156-66. PubMed ID: 19233164
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ontogeny and kinetics of carnitine palmitoyltransferase in liver and skeletal muscle of the domestic felid (Felis domestica).
    Lin X; House R; Odle J
    J Nutr Biochem; 2005 Jun; 16(6):331-8. PubMed ID: 15936644
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.
    Oikari S; Ahtialansaari T; Huotari A; Kiehne K; Fölsch UR; Wolffram S; Jänne J; Alhonen L; Herzig KH
    Acta Physiol (Oxf); 2008 Sep; 194(1):57-65. PubMed ID: 18394026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The absorption, distribution and biological effects of a modified fatty acid in its free form and as an ethyl ester in rats.
    Gudbrandsen OA; Wergedahl H; Bohov P; Berge RK
    Chem Biol Interact; 2009 May; 179(2-3):227-32. PubMed ID: 18992229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
    Seo YS; Kim JH; Jo NY; Choi KM; Baik SH; Park JJ; Kim JS; Byun KS; Bak YT; Lee CH; Kim A; Yeon JE
    J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on the lipid metabolism of Walker 256 tumour-bearing rats during the development of cancer cachexia.
    Seelaender MC; Nascimento CM; Curi R; Williams JF
    Biochem Mol Biol Int; 1996 Aug; 39(5):1037-47. PubMed ID: 8866022
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glucagon stimulates phosphorylation of different peptides in isolated periportal and perivenous hepatocytes.
    Aggarwal SR; Lindros KO; Palmer TN
    FEBS Lett; 1995 Dec; 377(3):439-43. PubMed ID: 8549772
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of liver carnitine palmitoyltransferase I and II genes during development in the rat.
    Thumelin S; Esser V; Charvy D; Kolodziej M; Zammit VA; McGarry D; Girard J; Pegorier JP
    Biochem J; 1994 Jun; 300 ( Pt 2)(Pt 2):583-7. PubMed ID: 8002965
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations.
    Ørngreen MC; Dunø M; Ejstrup R; Christensen E; Schwartz M; Sacchetti M; Vissing J
    Ann Neurol; 2005 Jan; 57(1):60-6. PubMed ID: 15622536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Partial characterization of a malonyl-CoA-sensitive carnitine O-palmitoyltransferase I from Macrobrachium borellii (Crustacea: Palaemonidae).
    Lavarías S; Pasquevich MY; Dreon MS; Heras H
    Comp Biochem Physiol B Biochem Mol Biol; 2009 Apr; 152(4):364-9. PubMed ID: 19171199
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic organization of freshwater, euryhaline, and marine elasmobranchs: implications for the evolution of energy metabolism in sharks and rays.
    Speers-Roesch B; Ip YK; Ballantyne JS
    J Exp Biol; 2006 Jul; 209(Pt 13):2495-508. PubMed ID: 16788033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo inhibition of Walker 256 tumour carnitine palmitoyltransferase I by soya oil dietary supplementation.
    Colquhoun A; de Mello FE; Curi R
    Biochem Mol Biol Int; 1998 Jan; 44(1):151-6. PubMed ID: 9503158
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance.
    Sebastián D; Herrero L; Serra D; Asins G; Hegardt FG
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E677-86. PubMed ID: 17062841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fatty acid oxidation in lymphocytes from Walker 256 tumor-bearing rats.
    Seelaender MC; Costa-Rosa LF; Curi R
    Braz J Med Biol Res; 1996 Apr; 29(4):445-51. PubMed ID: 8736106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel effect of C75 on carnitine palmitoyltransferase I activity and palmitate oxidation.
    Bentebibel A; Sebastián D; Herrero L; López-Viñas E; Serra D; Asins G; Gómez-Puertas P; Hegardt FG
    Biochemistry; 2006 Apr; 45(14):4339-50. PubMed ID: 16584169
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beta-hydoxy-beta-methylbutyrate supplementation affects Walker 256 tumor-bearing rats in a time-dependent manner.
    Caperuto EC; Tomatieli RV; Colquhoun A; Seelaender MC; Costa Rosa LF
    Clin Nutr; 2007 Feb; 26(1):117-22. PubMed ID: 17011676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disruption of lipid metabolism in the liver of the pregnant rat fed folate-deficient and methyl donor-deficient diets.
    McNeil CJ; Hay SM; Rucklidge GJ; Reid M; Duncan G; Maloney CA; Rees WD
    Br J Nutr; 2008 Feb; 99(2):262-71. PubMed ID: 17697402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.